Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826225 · ClinicalTrials.gov registry record
Cardiac Monitor Employee Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 20
- Enrollment target
NCT03826225: Completed study, sponsored by Boston Scientific Corporation.
NCT03826225 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03826225 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This purpose of this study is to collect ECG data from a wearable cardiac monitor in order to evaluate end-to-end performance of a cardiac monitor system and associated data management accessories.
Primary Outcome
Characterize rate of success of wireless data transmissions from wearable cardiac monitor to LATITUDE Clarity(TM) server
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-03-07 |
| Est. Completion | 2019-05-23 |
What the finished NCT03826225 record still lists
NCT03826225 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03826225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03826225 about?
NCT03826225 is a clinical study titled "Cardiac Monitor Employee Study". This purpose of this study is to collect ECG data from a wearable cardiac monitor in order to evaluate end-to-end performance of a cardiac monitor system and associated data management accessories.
What is the current status of trial NCT03826225?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-03-07. Estimated completion is 2019-05-23.
Who is sponsoring clinical trial NCT03826225?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI